CAMBRIDGE, Mass., July 25, 2008 (PRIME NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that clinical data for its rationally engineered anticoagulant, M118, will be presented at the upcoming IXth World Conference on Clinical Pharmacology and Therapeutics Meeting. The meeting will be held July 27 to August 1, 2008, in Quebec City, Quebec.
